Cargando…
Correction: Colon cancer-induced interleukin-35 inhibits betacatenin- mediated pro-oncogenic activity
Autores principales: | Jiang, Yueqiang, Ma, Yanling, Li, RuiChao, Sun, JianHai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114961/ https://www.ncbi.nlm.nih.gov/pubmed/30167095 http://dx.doi.org/10.18632/oncotarget.25959 |
Ejemplares similares
-
Retraction: Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity
por: Jiang, Yueqiang, et al.
Publicado: (2022) -
Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity
por: Jiang, QiangYue, et al.
Publicado: (2017) -
Correction to: Forkhead box (FOX) G1 promotes hepatocellular carcinoma epithelial-Mesenchymal transition by activating Wnt signal through forming T-cell factor-4/Betacatenin/FOXG1 complex
por: Zheng, Xingrong, et al.
Publicado: (2021) -
EXPRESSION OF E-CADHERIN AND WNT PATHWAY PROTEINS BETACATENIN, APC, TCF-4 AND SURVIVIN IN GASTRIC ADENOCARCINOMA: CLINICAL AND PATHOLOGICAL IMPLICATION
por: LINS, Rodrigo Rego, et al.
Publicado: (2016) -
Interleukin-35 expression is associated with colon cancer progression
por: Zhang, Jian, et al.
Publicado: (2017)